News & Updates

Upgrade Subscription

20 January 2025

Industry News

Eli Lilly to Construct Hyderabad Capability Centre

Eli Lilly intends to double its current capacity in India with the construction of a Hyderabad site similar to its global capability centre (GCC) situated in Bengaluru.

The Lilly Capability Centre India (LCCI), as the Hyderabad facility has been dubbed, will expand the company’s capabilities in automation, artificial intelligence, software product engineering and cloud computing. The site is expected to be operational this year.

Get started today.

PharmaChem Investor is your all-in-one solution for making strategic decisions, and driving innovation in the dynamic world of pharmaceuticals.

We notice you're using a small screen...

PharmaChem Investor is designed and optimised best for desktop devices and large screens, to make the most of all of the data available. We recommend accessing the site on a desktop device.

Logout